Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Aptamer specific for myeloid derived suppressor cells for the diagnosis of head and neck cancer from the oral rinse

Award Number: R21DE032157
ORGANIZATION: NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 03/15/2023
PERIOD OF PERFORMANCE END DATE: 03/14/2026

Group Awards By:

View Award Description

Aptamer specific for myeloid derived suppressor cells for the diagnosis of head and neck cancer from the oral rinse - The development of sensitive and specific diagnostic assays for the early detection of Head and Neck Cancer is still an unmet medical need. Most assays being developed rely on a neoplastic cell biomarker often present in only a proportion of neoplastic cells and/or a subset of patients with Head and Neck Squamous Cell carcinoma (HNSCC). As such, the intrinsic heterogeneity of the neoplastic cell within a single patient and across patients de facto limits the sensitivity of these assays. To overcome this problem, we propose to monitor HNSCC presence in the oral rinse using RNA aptamers that recognize tumor-infiltrating myeloid cells. These cells infiltrate the lesion in high numbers and early during tumorigenesis, participate in tumor initiation and progression, and predict recurrence in HNSCC. Additionally, these cells are quickly renewed in the tumor microenvironment and release their content in the tumor microenvironment and nearby fluid. We identified four RNA aptamers that recognize myeloid derived suppressor cells and macrophages in the HNSCC tumor but not the myeloid counterparts in the blood or healthy tissues in all patients evaluated. Additionally, our feasibility and proof of principle experiments indicate that these aptamers might discriminate oral rinses of patients with head and neck cancers from those of healthy donors. We propose to test the hypothesis that MDSC-specific aptamers used in linear surface plasmon resonance (LSPR) experiments can detect HNSCC from the oral rinse with high sensitivity and specificity. We will first optimize the assay using samples already banked in our institution. Then, we will perform a prospective clinical study in which we will test oral rinses from 150 patients with biopsy-proven HNSCC (all stage, all sites) and 150 age-matched healthy donors. In particular, we will compare side-by-side the sensitivity and specificity of LSPR assays using as ligand either our MDSC specific aptamers or an antibody against CD44, a marker strongly associated with HNSCC that is being developed for HNSCC diagnosis from the oral rinse with promising results. In summary, we propose a novel approach for the early diagnosis of HNSCC, a disease often diagnosed only in advanced stages when the prognosis is poor, and the treatment morbidity is high. Should our hypothesis be true, we anticipate that assays based on the presence of MDSC may aid in detecting this malignancy at earlier stages when treatments are most effective and less invasive.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $0 )
2026	2024	UNIVERSITY OF MIAMI	1320 S DIXIE HWY STE 1200	CORAL GABLES	FL	33146	MIAMI-DADE	USA	Oral Diseases and Disorders Research	000	2	5/26/2026	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2024 ( Subtotal = $230,250 )
2024	2024	UNIVERSITY OF MIAMI	1320 S DIXIE HWY STE 1200	CORAL GABLES	FL	33146	MIAMI-DADE	USA	Oral Diseases and Disorders Research	001	2	6/6/2024	NON-COMPETING CONTINUATION	$23,025
2024	2024	UNIVERSITY OF MIAMI	1320 S DIXIE HWY STE 1200	CORAL GABLES	FL	33146	MIAMI-DADE	USA	Oral Diseases and Disorders Research	000	2	2/21/2024	NON-COMPETING CONTINUATION	$207,225
														Subtotal = $230,250

Issue Date FY: 2023 ( Subtotal = $191,875 )
2023	2023	UNIVERSITY OF MIAMI	1400 NW 10TH AVE	MIAMI	FL	33136	MIAMI-DADE	USA	Oral Diseases and Disorders Research	000	1	3/6/2023	NEW	$191,875
														Subtotal = $191,875

Grand Total All Awards = $422,125

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Aptamer specific for myeloid derived suppressor cells for the diagnosis of head and neck cancer from the oral rinse

Award Number: R21DE032157

ORGANIZATION: NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 03/15/2023

PERIOD OF PERFORMANCE END DATE: 03/14/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer